Remi Health

Remi Health provides a Diagnostics-as-a-Service platform that lets companies offer lab diagnostics inside their own products through one API or a white-label journey. The service covers sample kits and collection, connections to accredited partner laboratories, medical review, and digital result delivery.

Its customers are payers and insurers, digital health, longevity and pharma companies, CROs and healthcare providers, which embed the service under their own brand. The website describes a single integration and offers a custom quote for its full test catalogue; no other pricing model is stated.

The company is based in Berlin and reports three markets live in the DACH region (Germany, Austria, Switzerland) with six more markets opening soon. In March 2026 it announced a €3 million seed round, bringing total funding to €5 million, led by IBB Ventures. Its open roles in Berlin include sales, operations, supply chain and customer success.

Product: Diagnostics-as-a-Service platform: one API or white-label journey covering test kits, sample collection, partner lab network, medical review and result delivery.